Evaluation of anti-inflammatory and antimicrobial activity of AHPL/AYCAP/0413 capsule

Sanjay Nipanikar; Sohan Chitlange; Dheeraj Nagore

doi:10.4103/0974-8490.210328

Users Online:731

ORIGINAL ARTICLE

Year : 2017 | Volume : 9 | Issue : 3 | Page : 273-276

Evaluation of anti-inflammatory and antimicrobial activity of AHPL/AYCAP/0413 capsule

Sanjay Nipanikar¹, Sohan Chitlange², Dheeraj Nagore³
¹ Head- R & D, R & D Center, Ari Healthcare Private Limited, Unit No. 401, International Biotech Park, BTS 2 Building, Chrysalis Enclave, 4^th Floor, Plot No – 2A, MIDC Phase II, Hinjewadi, Pune, Maharashtra, India
² Principal, Padm. Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pune, Maharashtra, India
³ Manager – Analytical Department, R & D Center, Ari Healthcare Private Limited, Unit No. 401, International Biotech Park, BTS 2 Building, Chrysalis Enclave, 4^th Floor, Plot No – 2A, MIDC Phase II, Hinjewadi, Pune, Maharashtra, India

Correspondence Address:
Sanjay Nipanikar
Head R & D, R & D Center, Ari Healthcare Private Limited, Unit No. 401, International Biotech Park, BTS 2 Building, Chrysalis Enclave, 4^th Floor, Plot No . 2A, MIDC Phase II, Hinjewadi, Pune, Maharashtra
India

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/0974-8490.210328

Background: Conventional therapeutic agents used for treatment of Acne are associated with various adverse effects necessitating development of safe and effective alternative therapeutic agents. In this context, a polyherbal formulation AHPL/AYCAP/0413 was developed for treatment of Acne. Objectives: To evaluate Anti-inflammatory and antimicrobial activity of AHPL/AYCAP/0413. Material and Methods: 1) Anti-inflammatory activity: Anti-inflammatory activity of AHPL/AYCAP/0413 in comparison with Diclofenac was assessed in carrageenan induced rat Paw edema model. 2) Anti-microbial activity for P. acne: Propionibacterium acnes were incubated under anaerobic conditions. Aliquots of molten BHI with glucose agar were used as the agar base. Formulation and clindamycin (10 μg/ml) were introduced in to the Agar wells randomly. 3) Anti-microbial activity for Staphylococcus epidermidis and Staphylococcus aureus: Staphylococcus epidermidis and Staphylococcus aureus were incubated under aerobic conditions at 37°C. TSB with glucose agar was used as the agar base. 0.5ml of formulation and clindamycin (10 μg/ml) were introduced in to the wells randomly. The antibacterial activity was evaluated by measuring zones of inhibition (in mm). Result: Significant reduction in rat paw edema (51% inhibition) was observed with formulation AHPL/AYCAP/0413 which was also comparable to that of Diclofenac (58% inhibition). Zone of inhibition for formulation was 18.33 mm, 19.20 mm and 26.30 mm for P. acnes, S. epidermidis and S. aureus respectively. This activity was also comparable to that of Clindamycin. Conclusion: AHPL/AYCAP/0413 capsule possesses significant Anti-inflammatory and Anti-microbial activities which further justifies its role in the management of Acne vulgaris.

[FULL TEXT] [PDF]*

Table of Contents

Similar in PUBMED

Search Pubmed for

Search in Google Scholar for

Related articles

Citation Manager

Access Statistics

Reader Comments

Email Alert *

Add to My List *

* Requires registration (Free)

Article Access Statistics

Viewed	2461

Printed	66

Emailed	0

PDF Downloaded	65

Comments	[Add]